New Horizons in Amyloidosis (NHA)

Dr Rodney Falk is a prominent figure in the field of cardiology, holding the esteemed position of director for the Cardiac Amyloidosis Program and serving as a specialist in cardiovascular medicine at Brigham and Women's Hospital (BWH). In addition, he is an associate professor of medicine at Harvard Medical School, reflecting his involvement in both clinical practice and academia. 

Dr Falk's academic journey commenced with the acquisition of his medical degree from the University of Birmingham Medical School in the United Kingdom. His rigorous training encompasses a trio of residencies: one in internal medicine at Brook General Hospital, another in internal medicine at City Hospital, and a cardiology program at King's College Hospital, all situated in London, UK. Complementing his extensive background, he furthered his expertise with a cardiology fellowship at Harvard School of Public Health, emphasizing his dedication to continued learning and…

Prof Philip Hawkins is a Professor of Medicine at University College London and Clinical Director of the NHS National Amyloidosis Centre at The Royal Free, London, UK. He is a rheumatologist and clinical scientist renowned for his studies on amyloidosis. His seminal work includes development and implementation of serum amyloid P component (SAP) scintigraphy for diagnosis and quantification of systemic amyloidosis.

Prof Hawkin’s clinical research programme is focused on diagnosis, pathogenesis, monitoring and treatment of amyloidosis and inherited autoinflammatory diseases with an emphasis on translational, early phase and otherwise novel approaches. He has a particular interest in the development of new imaging methods.

Isabelle Lousada stands as a driving force behind Amyloidosis Research Consortium, where she has spearheaded successful collaborations and programs across various sectors to propel the science and understanding of amyloidosis diseases forward. What makes her story even more remarkable is that she is not just a dedicated leader in the field, she is also a survivor.

Having been diagnosed with AL amyloidosis, Isabelle became one of the pioneers to undergo a stem cell transplant successfully. Her personal journey, from patient to advocate, showcases a tenacity and resilience that has undoubtedly fueled her efforts in advancing research and support for those affected by amyloidosis. It's individuals like Isabelle who remind us of the incredible impact one person can have on the pursuit of knowledge and the betterment of others' lives.